ClinicalTrials.gov
public full text
Public Domain
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma
This study is to assess the safety of an investigational drug in children 4 to 11 years of age who have asthma. The subjects will attend 7 clinic visits, of which up to 3 will be in the morning, and have lung function tests performed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)#969966
- Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study#879439
- Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)#1337001
- Using Tests in Preschool Children With Wheeze to Determine the Need for Inhaled Corticosteroid Therapy.#872953
- The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience#1328467
Record · ID 1232006
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive